or B-VEC), a topical gene therapy for treating wounds in patients with dystrophic epidermolysis bullosa (DEB) who have specific genetic mutations. The recommendation allows for administration in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback